マーケットレポート詳細
In Vitro毒性試験の世界市場：製品サービス別、毒性試験別2028年予測
In Vitro Toxicology Testing Market by Product & Service (Assays (ELISA & Western Blot), Equipment, Consumable, Software), Toxicity Endpoints (ADME, Genotoxicity, Cytotoxicity), Technology, Method, Industry (Pharma, Cosmetics) - Global Forecast to 2028
- 出版元：MarketsandMarkets
出版元について - 発行年：2023年10月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文414ページになります。
- 商品コード：MAM3448
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
In Vitro毒性試験の世界市場規模は2023年で108億ドル、2028年に171億ドル、市場の平均年成長率は9.5%で推移する見通しです。
レポートはIn Vitro毒性試験の世界市場について2028年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（製品/サービス別市場、毒性エンドポイント/試験別市場、等）を中心に構成されています。また競合状況、主要企業情報（15社）、バリューチェーン分析、技術分析などの分析も加味し、In Vitro毒性試験市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆In Vitro毒性試験の世界市場予測2021-2028年
・市場規模(US$)
◆製品/サービス別、市場-2028年
消耗品
アッセイ
・細菌毒性アッセイ
・酵素毒性アッセイ
・セルベースELISA/ウェスタンブロッティングアッセイ
・受容体結合アッセイ
・細胞培養アッセイ
・その他アッセイ
サービス
装置
ソフトウェア
※(市場規模US$)
◆毒性エンドポイント/試験別、市場-2028年
・ADME（吸収/分布/代謝/排泄）
・遺伝毒性
・皮膚刺激性/腐食性/感作性
・細胞毒性
・眼毒性
・臓器毒性
・皮膚毒性
・光毒性
・その他毒性エンドポイント/試験
※(市場規模US$)
◆産業別、市場-2028年
・製薬/バイオ医薬品
・コンシューマーケア
・食品
・その他産業
※(市場規模US$)
◆技術別、市場-2028年
・細胞培養
・HTS（ハイスループットスクリーニング）
・トキシコゲノミクス
※(市場規模US$)
◆メソッド別、市場-2028年
・細胞アッセイ
・生化学アッセイ
・分子毒性アッセイ
・Ex vivoモデル
・In silicoモデル
※(市場規模US$)
◆主要国地域別市場-2028年
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
北米
・米国、カナダ
アジア太平洋
・日本、中国、インド、韓国
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・中東
・アフリカ
※国地域別に全セグメントの細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス（促進要因、障壁、機会、課題）
・プライシング分析
・バリューチェーン分析
・サプライチェーン分析
・エコシステム分析
・特許分析
・技術分析
・業界構造分析
・競合状況
・市場シェア分析
◆In Vitro毒性試験の主要企業プロフィール動向
・THERMO FISHER SCIENTIFIC INC
・AGILENT TECHNOLOGIES, INC
・MERCK KGAA
・LABORATORY CORPORATION OF AMERICA HOLDINGS
・EUROFINS SCIENTIFIC
・CHARLES RIVER LABORATORIES
・SGS SA
・REVVITY
・BIO-RAD LABORATORIES, INC
・LONZA
・EVOTEC SE
・CATALENT, INC
・INTERTEK GROUP PLC
・INOTIV
・PROMEGA CORPORATION
その他企業
・BIOIVT
・CREATIVE BIOLABS
・SHANGHAI MEDICILON INC
・CREATIVE BIOARRAY
・ARAGEN LIFE SCIENCES LTD
・ENZO BIOCHEM INC
・MICROBAC LABORATORIES, INC
・VIMTA LABS LTD
・PACIFIC BIOLABS, INC
・MB RESEARCH LABORATORIES
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS OF STUDY
1.2.2 MARKETS COVERED 51
・ FIGURE 1 IN VITRO TOXICOLOGY TESTING MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED 52
1.3 CURRENCY
1.4 STAKEHOLDERS
1.5 LIMITATIONS 53
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
・ FIGURE 3 IN VITRO TOXICOLOGY TESTING MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
・ FIGURE 4 IN VITRO TOXICOLOGY TESTING: MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
・ FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
・ FIGURE 6 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2022
2.2.1 INSIGHTS FROM PRIMARIES
・ FIGURE 7 MARKET VALIDATION FROM PRIMARY EXPERTS
・ FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
・ FIGURE 9 IN VITRO TOXICOLOGY TESTING MARKET: CAGR PROJECTIONS
・ FIGURE 10 IN VITRO TOXICOLOGY TESTING MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
・ FIGURE 11 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 RECESSION IMPACT ANALYSIS
・ TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)
・ TABLE 2 US: HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
・ TABLE 3 US: HEALTH EXPENDITURE, 2023–2030 (USD MILLION)
3 EXECUTIVE SUMMARY
・ FIGURE 12 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
・ FIGURE 13 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2023 VS. 2028 (USD MILLION)
・ FIGURE 14 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
・ FIGURE 15 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2023 VS. 2028 (USD MILLION)
・ FIGURE 16 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2023 VS. 2028 (USD MILLION)
・ FIGURE 17 GEOGRAPHICAL SNAPSHOT OF IN VITRO TOXICOLOGY TESTING MARKET
4 PREMIUM INSIGHTS
4.1 IN VITRO TOXICOLOGY TESTING MARKET OVERVIEW
・ FIGURE 18 PUBLIC RESISTANCE AGAINST ANIMAL TESTING TO DRIVE MARKET
4.2 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD AND COUNTRY (2022)
・ FIGURE 19 CELLULAR ASSAYS ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC IN VITRO TOXICOLOGY TESTING MARKET IN 2022
4.3 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・ FIGURE 20 GERMANY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
4.4 IN VITRO TOXICOLOGY TESTING MARKET SHARE, BY PRODUCT & SERVICE, 2022
・ FIGURE 21 CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 22 IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
・ TABLE 4 IN VITRO TOXICOLOGY TESTING MARKET: IMPACT ANALYSIS
5.2.1 MARKET DRIVERS
5.2.1.1 GROWING PUBLIC RESISTANCE AGAINST ANIMAL TESTING
・ FIGURE 23 HISTORY OF EU BAN ON ANIMAL TESTING FOR COSMETICS
5.2.1.2 TECHNOLOGICAL ADVANCEMENTS
5.2.1.3 RESEARCH AND DEVELOPMENT EFFORTS AIMED AT EARLY-STAGE TOXICITY DETECTION
・ FIGURE 24 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2028 (USD BILLION)
5.2.2 MARKET RESTRAINTS 81
5.2.2.1 RESISTANCE OF CERTAIN REGULATORY BODIES TO EMBRACE ALTERNATIVE APPROACHES IN TOXICOLOGY TESTING
5.2.2.2 FAILURE TO ESTABLISH INTRICACIES OF IN VIVO CONDITIONS
5.2.2.3 LACK OF IN VITRO MODELS TO STUDY COMPLEX ENDPOINTS
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 GROWING FOCUS ON DRUG DISCOVERY AND PERSONALIZED MEDICINE USING IN VITRO METHODS
5.2.3.2 INCREASING NUMBER OF TOXICOLOGY DATABASES
・ TABLE 5 CHEMICAL TOXICITY DATABASES
5.2.3.3 INCREASING FOCUS ON PREDICTIVE TOXICOLOGY
5.2.4 MARKET CHALLENGES 85
5.2.4.1 LACK OF DATA AVAILABILITY AND VALIDATION
5.2.4.2 COMPLEXITY IN DATA ANALYSIS AND MANAGEMENT
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
・ FIGURE 25 REVENUE SHIFT & NEW POCKETS FOR IN VITRO TOXICOLOGY TESTING PRODUCT/SERVICE PROVIDERS
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE OF IN VITRO TOXICOLOGY TESTING PRODUCTS, BY KEY PLAYER, 2022
・ TABLE 6 AVERAGE SELLING PRICE OF IN VITRO TOXICOLOGY TESTING PRODUCTS, BY KEY PLAYER
5.4.2 AVERAGE SELLING PRICE OF IN VITRO TOXICOLOGY TESTING PRODUCTS, BY REGION, 2022
・ TABLE 7 AVERAGE SELLING PRICE OF IN VITRO TOXICOLOGY TESTING PRODUCTS, BY REGION
5.4.3 AVERAGE SELLING PRICE TREND
5.5 VALUE CHAIN ANALYSIS
・ FIGURE 26 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING PRODUCT DEVELOPMENT AND MANUFACTURING PHASE
5.6 SUPPLY CHAIN ANALYSIS
・ FIGURE 27 SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
5.7 ECOSYSTEM ANALYSIS
・ FIGURE 28 ECOSYSTEM ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
・ TABLE 8 ECOSYSTEM FOR IN VITRO TOXICOLOGY TESTING MARKET
5.8 PATENT ANALYSIS
・ FIGURE 29 IN VITRO TOXICOLOGY TESTING MARKET: PATENTS GRANTED (JANUARY 2013–SEPTEMBER 2023)
5.9 TECHNOLOGY ANALYSIS
5.10 KEY CONFERENCES & EVENTS, 2023–2024
・ TABLE 9 IN VITRO TOXICOLOGY TESTING MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.11 REGULATORY LANDSCAPE
5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 13 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2 REGULATORY SCENARIO
・ TABLE 14 IN VITRO TOXICOLOGY TESTING MARKET: REGULATORY SCENARIO
5.12 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 15 PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF SUPPLIERS
5.12.4 BARGAINING POWER OF BUYERS
5.12.5 INTENSITY OF COMPETITIVE RIVALRY
5.13 KEY STAKEHOLDERS & BUYING CRITERIA
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
・ FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF IN VITRO TOXICOLOGY TESTING
5.13.2 BUYING CRITERIA FOR IN VITRO TOXICITY TESTING
・ FIGURE 31 KEY BUYING CRITERIA FOR END USERS
6 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
・ TABLE 16 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 CONSUMABLES 107
6.2.1 INCREASING DEMAND FOR HIGH-QUALITY REAGENTS TO DRIVE MARKET
・ TABLE 17 IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 18 EUROPE: IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 19 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
・ TABLE 20 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
・ TABLE 21 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 109
・ TABLE 22 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3 ASSAYS
・ TABLE 23 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 24 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 25 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 26 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 27 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 28 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 29 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.1 BACTERIAL TOXICITY ASSAYS
6.3.1.1 HIGH SAMPLE THROUGHPUT AND RAPID RESPONSE TO TOXICANTS TO DRIVE ADOPTION
・ TABLE 30 BACTERIAL TOXICITY ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 31 EUROPE: BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 32 NORTH AMERICA: BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 33 ASIA PACIFIC: BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 34 LATIN AMERICA: BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 35 MIDDLE EAST & AFRICA: BACTERIAL TOXICITY ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.2 ENZYME TOXICITY ASSAYS
6.3.2.1 INCREASINGLY USED IN ENDOCRINE-DISRUPTING STUDIES
・ TABLE 36 ENZYME TOXICITY ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 37 EUROPE: ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 38 NORTH AMERICA: ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 39 ASIA PACIFIC: ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 40 LATIN AMERICA: ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 41 MIDDLE EAST & AFRICA: ENZYME TOXICITY ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.3 CELL-BASED ELISA & WESTERN BLOTTING ASSAYS
6.3.3.1 SIMPLE, FAST, AND COST-EFFECTIVE ALTERNATIVES TO LARGE-SCALE AND COST-INTENSIVE ANIMAL TESTING
・ TABLE 42 CELL-BASED ELISA & WESTERN BLOTTING ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 43 EUROPE: CELL-BASED ELISA & WESTERN BLOTTING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 44 NORTH AMERICA: CELL-BASED ELISA & WESTERN BLOTTING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 45 ASIA PACIFIC: CELL-BASED ELISA & WESTERN BLOTTING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 46 LATIN AMERICA: CELL-BASED ELISA & WESTERN BLOTTING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 47 MIDDLE EAST & AFRICA: CELL-BASED ELISA & WESTERN BLOTTING ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.4 RECEPTOR-BINDING ASSAYS
6.3.4.1 SUITABLE FOR HIGH-THROUGHPUT FORMATS
・ TABLE 48 RECEPTOR-BINDING ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 49 EUROPE: RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 50 NORTH AMERICA: RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 51 ASIA PACIFIC: RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 52 LATIN AMERICA: RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 53 MIDDLE EAST & AFRICA: RECEPTOR-BINDING ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.5 TISSUE CULTURE ASSAYS
6.3.5.1 INCREASING COST OF ANIMAL STUDIES TO PROPEL MARKET
・ TABLE 54 TISSUE CULTURE ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 55 EUROPE: TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 56 NORTH AMERICA: TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 57 ASIA PACIFIC: TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 58 LATIN AMERICA: TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 59 MIDDLE EAST & AFRICA: TISSUE CULTURE ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.6 OTHER ASSAYS
・ TABLE 60 OTHER ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 61 EUROPE: OTHER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 62 NORTH AMERICA: OTHER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 63 ASIA PACIFIC: OTHER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 64 LATIN AMERICA: OTHER ASSAYS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 65 MIDDLE EAST & AFRICA: OTHER ASSAYS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.4 SERVICES
6.4.1 LACK OF INFRASTRUCTURE AND EXPERTISE IN RESEARCH CENTERS TO SUPPORT MARKET GROWTH
・ TABLE 66 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 67 EUROPE: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 68 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 69 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 70 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 71 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.5 EQUIPMENT 134
6.5.1 ADOPTION OF ADVANCED TESTING EQUIPMENT TO MEET NEW REGULATORY STANDARDS TO PROPEL MARKET
・ TABLE 72 IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 73 EUROPE: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 74 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 75 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 76 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 77 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
6.6 SOFTWARE
6.6.1 CRUCIAL ROLE IN DECREASING ANALYSIS TIME AND EFFECTIVELY HANDLING SUBSTANTIAL DATA VOLUMES
・ TABLE 78 IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 79 EUROPE: IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 80 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 81 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 82 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 83 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION)
7 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST
7.1 INTRODUCTION
・ TABLE 84 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2021–2028 (USD MILLION)
7.2 ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION
7.2.1 PRODUCES HIGHLY REPRODUCIBLE & ACCURATE DATA
・ TABLE 85 IN VITRO ADME TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 86 EUROPE: IN VITRO ADME TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 87 NORTH AMERICA: IN VITRO ADME TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 88 ASIA PACIFIC: IN VITRO ADME TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 89 LATIN AMERICA: IN VITRO ADME TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 90 MIDDLE EAST & AFRICA: IN VITRO ADME TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3 GENOTOXICITY
7.3.1 RIGOROUS REGULATORY REQUIREMENTS FOR NEW DRUGS TO AID MARKET GROWTH
・ TABLE 91 IN VITRO GENOTOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 92 EUROPE: IN VITRO GENOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 93 NORTH AMERICA: IN VITRO GENOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 94 ASIA PACIFIC: IN VITRO GENOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 95 LATIN AMERICA: IN VITRO GENOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 96 MIDDLE EAST & AFRICA: IN VITRO GENOTOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
7.4 SKIN IRRITATION, CORROSION, & SENSITIZATION
7.4.1 MAJOR ENDPOINTS STUDIED IN COSMETICS INDUSTRY
・ TABLE 97 IN VITRO SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 98 EUROPE: IN VITRO SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 99 NORTH AMERICA: IN VITRO SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 100 ASIA PACIFIC: IN VITRO SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 101 LATIN AMERICA: IN VITRO SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 102 MIDDLE EAST & AFRICA: IN VITRO SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
7.5 CYTOTOXICITY
7.5.1 RISING NEED FOR BIOSAFETY TO SUPPORT MARKET GROWTH
・ TABLE 103 IN VITRO CYTOTOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 104 EUROPE: IN VITRO CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 105 NORTH AMERICA: IN VITRO CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 106 ASIA PACIFIC: IN VITRO CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 107 LATIN AMERICA: IN VITRO CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 108 MIDDLE EAST & AFRICA: IN VITRO CYTOTOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
7.6 OCULAR TOXICITY
7.6.1 IN VITRO AND EX VIVO TECHNIQUES INCREASINGLY GAINING ATTENTION FOR EVALUATION OF OCULAR TOXICITY
・ TABLE 109 IN VITRO OCULAR TOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 110 EUROPE: IN VITRO OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 111 NORTH AMERICA: IN VITRO OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 112 ASIA PACIFIC: IN VITRO OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 113 LATIN AMERICA: IN VITRO OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 114 MIDDLE EAST & AFRICA: IN VITRO OCULAR TOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
7.7 ORGAN TOXICITY
7.7.1 FASTEST-GROWING SEGMENT OF MARKET
・ TABLE 115 IN VITRO ORGAN TOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 116 EUROPE: IN VITRO ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 117 NORTH AMERICA: IN VITRO ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 118 ASIA PACIFIC: IN VITRO ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 119 LATIN AMERICA: IN VITRO ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 120 MIDDLE EAST & AFRICA: IN VITRO ORGAN TOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
7.8 DERMAL TOXICITY
7.8.1 ONGOING GOVERNMENT INITIATIVES AND CHANGES IN REGULATORY GUIDELINES TO SUPPORT MARKET GROWTH
・ TABLE 121 IN VITRO DERMAL TOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 122 EUROPE: IN VITRO DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 123 NORTH AMERICA: IN VITRO DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 124 ASIA PACIFIC: IN VITRO DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 125 LATIN AMERICA: IN VITRO DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 126 MIDDLE EAST & AFRICA: IN VITRO DERMAL TOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
7.9 PHOTOTOXICITY
7.9.1 ESTABLISHED NON-ANIMAL TECHNIQUES EMPLOYED TO ASSESS PHOTOTOXICITY OF COSMETICS, PHARMACEUTICALS, AND CHEMICALS
・ TABLE 127 IN VITRO PHOTOTOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 128 EUROPE: IN VITRO PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 129 NORTH AMERICA: IN VITRO PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 130 ASIA PACIFIC: IN VITRO PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 131 LATIN AMERICA: IN VITRO PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 132 MIDDLE EAST & AFRICA: IN VITRO PHOTOTOXICITY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
7.10 OTHER ENDPOINTS & TESTS
・ TABLE 133 OTHER IN VITRO ENDPOINTS & TESTS MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 134 EUROPE: OTHER IN VITRO ENDPOINTS & TESTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 135 NORTH AMERICA: OTHER IN VITRO ENDPOINTS & TESTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 136 ASIA PACIFIC: OTHER IN VITRO ENDPOINTS & TESTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 137 LATIN AMERICA: OTHER IN VITRO ENDPOINTS & TESTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 138 MIDDLE EAST & AFRICA: OTHER IN VITRO ENDPOINTS & TESTS MARKET, BY REGION, 2021–2028 (USD MILLION) 168
8 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY
8.1 INTRODUCTION
・ TABLE 139 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
8.2 PHARMACEUTICAL & BIOPHARMACEUTICAL
8.2.1 GROWING R&D EXPENDITURE TO FAVOR MARKET GROWTH
・ TABLE 140 IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 141 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 142 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 143 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 144 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 145 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
8.3 CONSUMER CARE
8.3.1 GROWING DEMAND FOR CRUELTY-FREE COSMETICS AND PERSONAL CARE PRODUCTS TO DRIVE MARKET
・ TABLE 146 IN VITRO TOXICOLOGY TESTING MARKET FOR CONSUMER CARE INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 147 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 148 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 149 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 150 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 151 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CONSUMER CARE INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
8.4 FOOD
8.4.1 INCREASING FOCUS ON FOOD SAFETY TO PROPEL MARKET
・ TABLE 152 TYPES OF TOXICOLOGY TESTS FOR FOOD
・ TABLE 153 IN VITRO TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 154 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 155 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 180
・ TABLE 156 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 180
・ TABLE 157 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION) 180
・ TABLE 158 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR FOOD INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
8.5 OTHER INDUSTRIES
・ TABLE 159 IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 160 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 161 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 162 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 163 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 164 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR OTHER INDUSTRIES, BY REGION, 2021–2028 (USD MILLION)
9 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY
9.1 INTRODUCTION
・ TABLE 165 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
9.2 CELL CULTURE
9.2.1 MOST PREFERRED TECHNIQUE FOR TOXICITY TESTING
・ TABLE 166 IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 167 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 168 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 169 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 170 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 171 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE, BY REGION, 2021–2028 (USD MILLION)
9.3 HIGH-THROUGHPUT SCREENING
9.3.1 INCREASING USE OF HIGH-CONTENT IMAGING TECHNOLOGIES IN TOXICITY TESTING TO BOOST MARKET GROWTH 189
・ TABLE 172 IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT SCREENING, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 173 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 174 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 175 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 176 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 177 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT SCREENING, BY REGION, 2021–2028 (USD MILLION)
9.4 TOXICOGENOMICS
9.4.1 TECHNOLOGICAL ADVANCEMENTS IN PROTEOMICS AND GENOMICS TO DRIVE MARKET
・ TABLE 178 IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 179 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 180 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021–2028 (USD MILLION) 194
・ TABLE 181 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021–2028 (USD MILLION) 194
・ TABLE 182 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2021–2028 (USD MILLION) 194
・ TABLE 183 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY REGION, 2021–2028 (USD MILLION)
10 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD
10.1 INTRODUCTION
・ TABLE 184 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
10.2 CELLULAR ASSAYS
10.2.1 DEVELOPMENT OF MULTIPARAMETER ASSAYS TO PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES FOR MARKET PLAYERS
・ TABLE 185 IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 186 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 187 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION) 199
・ TABLE 188 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION) 199
・ TABLE 189 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION) 199
・ TABLE 190 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY REGION, 2021–2028 (USD MILLION)
10.3 BIOCHEMICAL ASSAYS
10.3.1 HELP REFLECT UPON UNNATURAL CHANGES INDUCED BY TEST SUBSTANCES
・ TABLE 191 IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 192 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION) 201
・ TABLE 193 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 194 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 195 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 196 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS, BY REGION, 2021–2028 (USD MILLION)
10.4 MOLECULAR TOXICOLOGY ASSAYS
10.4.1 RISING INVESTMENTS IN MOLECULAR TOXICOLOGY TECHNOLOGIES TO DRIVE MARKET
・ TABLE 197 IN VITRO TOXICOLOGY TESTING MARKET FOR MOLECULAR TOXICOLOGY ASSAYS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 198 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR MOLECULAR TOXICOLOGY ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 199 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR MOLECULAR TOXICOLOGY ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 200 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR MOLECULAR TOXICOLOGY ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 201 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR MOLECULAR TOXICOLOGY ASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 202 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR MOLECULAR TOXICOLOGY ASSAYS, BY REGION, 2021–2028 (USD MILLION)
10.5 EX VIVO MODELS
10.5.1 RISING DEMAND FOR ALTERNATIVES TO ANIMAL TESTING TO DRIVE MARKET
・ TABLE 203 IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 204 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 205 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY COUNTRY, 2021–2028 (USD MILLION) 208
・ TABLE 206 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY COUNTRY, 2021–2028 (USD MILLION) 208
・ TABLE 207 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY COUNTRY, 2021–2028 (USD MILLION) 208
・ TABLE 208 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS, BY REGION, 2021–2028 (USD MILLION)
10.6 IN SILICO MODELS
10.6.1 HELP REDUCE NUMBER OF SAMPLES TESTED
・ TABLE 209 IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 210 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 211 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 212 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 213 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 214 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS, BY REGION, 2021–2028 (USD MILLION)
11 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION
11.1 INTRODUCTION
・ TABLE 215 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
11.2 EUROPE
・ FIGURE 32 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
・ TABLE 216 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 217 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 218 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 219 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION) 217
・ TABLE 220 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 221 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 222 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.2.1 GERMANY
11.2.1.1 WELL-ESTABLISHED PHARMACEUTICALS INDUSTRY TO SUPPORT MARKET GROWTH
・ TABLE 223 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 224 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 225 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION) 221
・ TABLE 226 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 227 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 228 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.2.2 UK
11.2.2.1 RISING FOCUS ON RESEARCH ACTIVITIES AND ACADEMIA-INDUSTRY PARTNERSHIPS TO DRIVE MARKET
・ TABLE 229 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 230 UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 231 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION) 224
・ TABLE 232 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 233 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 234 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.2.3 FRANCE
11.2.3.1 INCREASING GOVERNMENT FUNDING FOR PROTEOMICS AND GENOMICS RESEARCH TO DRIVE MARKET
・ TABLE 235 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 236 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 237 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION) 228
・ TABLE 238 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 239 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 240 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.2.4 ITALY
11.2.4.1 INCREASING LIFE SCIENCES RESEARCH TO PROPEL MARKET
・ TABLE 241 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 242 ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 243 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION) 231
・ TABLE 244 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 245 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 246 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.2.5 SPAIN
11.2.5.1 GROWING CHEMICALS INDUSTRY TO SUPPORT MARKET GROWTH
・ TABLE 247 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 248 SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 249 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION) 234
・ TABLE 250 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 251 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 252 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.2.6 REST OF EUROPE
・ TABLE 253 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 254 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 255 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
・ TABLE 256 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 257 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 258 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.2.7 RECESSION IMPACT 239
11.3 NORTH AMERICA
・ TABLE 259 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 260 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 261 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 262 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
・ TABLE 263 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 264 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 265 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.3.1 US
11.3.1.1 GROWING FOCUS ON BIOMARKER DISCOVERY AND RESEARCH IN STRUCTURE-BASED DRUG DESIGN TO PROPEL MARKET
・ TABLE 266 US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 267 US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 268 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION) 246
・ TABLE 269 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 270 US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 271 US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.3.2 CANADA
11.3.2.1 STRONG SUPPORT TO CARRY OUT R&D IN PHARMACEUTICAL AND PROTEOMICS FIELDS TO BOOST MARKET GROWTH
・ TABLE 272 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 273 CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 274 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION) 249
・ TABLE 275 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 276 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 277 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.3.3 RECESSION IMPACT 251
11.4 ASIA PACIFIC
・ FIGURE 33 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
・ TABLE 278 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 279 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 280 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 281 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
・ TABLE 282 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 283 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 284 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.4.1 CHINA
11.4.1.1 INCREASING INTERNATIONAL PRESSURE TO BAN ANIMAL TESTING METHODS TO PROPEL MARKET
・ TABLE 285 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 286 CHINA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 287 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION) 259
・ TABLE 288 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 289 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 290 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 RISING DEMAND FOR TECHNOLOGICALLY ADVANCED RESEARCH PRODUCTS TO DRIVE MARKET
・ TABLE 291 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 292 JAPAN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 293 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION) 262
・ TABLE 294 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 295 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 296 JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.4.3 INDIA
11.4.3.1 GROWING FOCUS OF UNIVERSITIES ON AVOIDING USE OF ANIMALS TO TEST COSMETIC PRODUCTS TO PROPEL MARKET
・ TABLE 297 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 298 INDIA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 299 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION) 266
・ TABLE 300 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 301 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 302 INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.4.4 SOUTH KOREA
11.4.4.1 GROWING FOCUS OF GOVERNMENT TO INCREASE PHARMACEUTICAL SPENDING TO PROPEL MARKET GROWTH
・ TABLE 303 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 304 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 305 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION) 269
・ TABLE 306 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 307 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 308 SOUTH KOREA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.4.5 REST OF ASIA PACIFIC
・ TABLE 309 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 310 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 311 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
・ TABLE 312 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 313 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 314 REST OF ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.4.6 RECESSION IMPACT 274
11.5 LATIN AMERICA
・ TABLE 315 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 316 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 317 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 318 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
・ TABLE 319 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 320 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 321 LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.5.1 BRAZIL
11.5.1.1 ADOPTION OF NON-ANIMAL TESTING METHODS TO PROPEL MARKET
・ TABLE 322 BRAZIL: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 323 BRAZIL: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 324 BRAZIL: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION) 281
・ TABLE 325 BRAZIL: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 326 BRAZIL: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 327 BRAZIL: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.5.2 MEXICO
11.5.2.1 BAN ON ANIMAL TESTING FOR COSMETICS TO SUPPORT MARKET GROWTH
・ TABLE 328 MEXICO: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 329 MEXICO: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 330 MEXICO: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION) 284
・ TABLE 331 MEXICO: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 332 MEXICO: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 333 MEXICO: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.5.3 REST OF LATIN AMERICA
・ TABLE 334 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 335 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 336 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
・ TABLE 337 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 338 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 339 REST OF LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.5.4 RECESSION IMPACT 289
11.6 MIDDLE EAST & AFRICA
・ TABLE 340 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 341 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 342 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION) 291
・ TABLE 343 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION)
・ TABLE 344 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 292
・ TABLE 345 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 346 MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.6.1 MIDDLE EAST
11.6.1.1 GROWING FOCUS ON AI-BASED TECHNOLOGIES FOR DRUG DISCOVERY TO DRIVE MARKET
・ TABLE 347 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 348 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 349 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION) 295
・ TABLE 350 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 351 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 352 MIDDLE EAST: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.6.2 AFRICA
11.6.2.1 PRECISION MEDICINE INITIATIVES TO FUEL MARKET GROWTH
・ TABLE 353 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
・ TABLE 354 AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 355 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT & TEST, 2021–2028 (USD MILLION) 298
・ TABLE 356 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
・ TABLE 357 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021–2028 (USD MILLION)
・ TABLE 358 AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021–2028 (USD MILLION)
11.6.3 RECESSION IMPACT 299
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 STRATEGIES ADOPTED BY KEY PLAYERS
・ FIGURE 34 IN VITRO TOXICOLOGY TESTING MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
12.3 REVENUE SHARE ANALYSIS
・ FIGURE 35 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN IN VITRO TOXICOLOGY TESTING MARKET, 2018–2022
12.4 MARKET SHARE ANALYSIS
・ FIGURE 36 IN VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2022
・ TABLE 359 IN VITRO TOXICOLOGY TESTING MARKET: DEGREE OF COMPETITION
12.5 COMPANY EVALUATION MATRIX
12.5.1 STARS
12.5.2 EMERGING LEADERS 306
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
・ FIGURE 37 IN VITRO TOXICOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
12.5.5 COMPANY FOOTPRINT 308
・ TABLE 360 OVERALL FOOTPRINT ANALYSIS OF COMPANIES (2022)
12.5.5.1 PRODUCT/SERVICE FOOTPRINT ANALYSIS
・ TABLE 361 PRODUCT/SERVICE FOOTPRINT ANALYSIS OF COMPANIES (2022)
12.5.5.2 REGIONAL FOOTPRINT ANALYSIS
・ TABLE 362 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES (2022)
12.6 STARTUP/SME EVALUATION MATRIX
12.6.1 PROGRESSIVE COMPANIES
12.6.2 STARTING BLOCKS 311
12.6.3 RESPONSIVE COMPANIES
12.6.4 DYNAMIC COMPANIES
・ FIGURE 38 IN VITRO TOXICOLOGY TESTING MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022
12.6.5 COMPETITIVE BENCHMARKING
・ TABLE 363 IN VITRO TOXICOLOGY TESTING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
・ TABLE 364 IN VITRO TOXICOLOGY TESTING MARKET: COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS
12.7 COMPETITIVE SCENARIO
・ TABLE 365 KEY PRODUCT/SERVICE LAUNCHES 315
・ TABLE 366 KEY DEALS
・ TABLE 367 OTHER KEY DEVELOPMENTS
13 COMPANY PROFILES
(BUSINESS OVERVIEW, PRODUCTS & SERVICES OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
13.1 MAJOR PLAYERS
13.1.1 THERMO FISHER SCIENTIFIC INC.
・ TABLE 368 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
・ FIGURE 39 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
13.1.2 AGILENT TECHNOLOGIES, INC.
・ TABLE 369 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
・ FIGURE 40 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
13.1.3 MERCK KGAA
・ TABLE 370 MERCK KGAA: BUSINESS OVERVIEW
・ FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2022)
13.1.4 LABORATORY CORPORATION OF AMERICA HOLDINGS
・ TABLE 371 LABORATORY CORPORATION OF AMERICA HOLDINGS: BUSINESS OVERVIEW
・ FIGURE 42 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2022)
13.1.5 EUROFINS SCIENTIFIC
・ TABLE 372 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
・ FIGURE 43 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022)
13.1.6 CHARLES RIVER LABORATORIES
・ TABLE 373 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW
・ FIGURE 44 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022)
13.1.7 SGS SA
・ TABLE 374 SGS SA: BUSINESS OVERVIEW
・ FIGURE 45 SGS SA: COMPANY SNAPSHOT (2022)
13.1.8 REVVITY
・ TABLE 375 REVVITY: BUSINESS OVERVIEW 369
・ FIGURE 46 REVVITY: COMPANY SNAPSHOT (2022)
13.1.9 BIO-RAD LABORATORIES, INC.
・ TABLE 376 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
・ FIGURE 47 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
13.1.10 LONZA
・ TABLE 377 LONZA: BUSINESS OVERVIEW
・ FIGURE 48 LONZA: COMPANY SNAPSHOT (2022)
13.1.11 EVOTEC SE
・ TABLE 378 EVOTEC SE: BUSINESS OVERVIEW 383
・ FIGURE 49 EVOTEC SE: COMPANY SNAPSHOT (2022)
13.1.12 CATALENT, INC.
・ TABLE 379 CATALENT, INC.: BUSINESS OVERVIEW
・ FIGURE 50 CATALENT, INC.: COMPANY SNAPSHOT (2022)
13.1.13 INTERTEK GROUP PLC
・ TABLE 380 INTERTEK GROUP PLC: BUSINESS OVERVIEW
・ FIGURE 51 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2022)
13.1.14 INOTIV
・ TABLE 381 INOTIV: BUSINESS OVERVIEW
・ FIGURE 52 INOTIV: COMPANY SNAPSHOT (2022)
13.1.15 PROMEGA CORPORATION
・ TABLE 382 PROMEGA CORPORATION: BUSINESS OVERVIEW
13.2 OTHER PLAYERS
13.2.1 BIOIVT
・ TABLE 383 BIOIVT: COMPANY OVERVIEW
13.2.2 CREATIVE BIOLABS 409
・ TABLE 384 CREATIVE BIOLABS: COMPANY OVERVIEW
13.2.3 SHANGHAI MEDICILON INC.
・ TABLE 385 SHANGHAI MEDICILON INC.: COMPANY OVERVIEW
13.2.4 CREATIVE BIOARRAY 411
・ TABLE 386 CREATIVE BIOARRAY: COMPANY OVERVIEW
13.2.5 ARAGEN LIFE SCIENCES LTD.
・ TABLE 387 ARAGEN LIFE SCIENCES LTD.: COMPANY OVERVIEW
13.2.6 ENZO BIOCHEM INC. 414
・ TABLE 388 ENZO BIOCHEM INC.: COMPANY OVERVIEW
13.2.7 MICROBAC LABORATORIES, INC.
・ TABLE 389 MICROBAC LABORATORIES, INC.: COMPANY OVERVIEW
13.2.8 VIMTA LABS LTD. 418
・ TABLE 390 VIMTA LABS LTD.: COMPANY OVERVIEW
13.2.9 PACIFIC BIOLABS, INC.
・ TABLE 391 PACIFIC BIOLABS, INC.: COMPANY OVERVIEW
13.2.10 MB RESEARCH LABORATORIES
・ TABLE 392 MB RESEARCH LABORATORIES: COMPANY OVERVIEW
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS & SERVICES OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.